India's homegrown Covid-19 vaccine has 78% efficacy against symptomatic infections, developer says

India's homegrown Covid-19 vaccine Covaxin has an efficacy rate of more than 93.4% against severe Covid-19 infection and 77.8% against symptomatic infection, according to data released Saturday by the shot's developer.